New Taipei, Taiwan

Everfront Biotech Inc.

USPTO Granted Patents = 9


Forward Citations = 0

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Shinn-Zong Lin (8 out of 37 patents)

silverMedal Horng-Jyh Harn (8 out of 32 patents)

bronzeMedal Tzyy-Wen Chiou (6 out of 20 patents)

4.  Hong-Lin Su (3 out of 8 patents)

5.  Ssu-Yin Yen (2 out of 2 patents)

6.  Sheng-Feng Tsai (1 out of 4 patents)

7.  Chia-Yu Chang (1 out of 2 patents)

8.  Huai-En Lu (1 out of 2 patents)

9.  Shiaw-Min Hwang (1 out of 9 patents)

10.  Ping-Shan Lai (1 out of 3 patents)

11.  Hong-Meng Chuang (1 out of 1 patent)

12.  Cheng-Han Wu (1 out of 4 patents)

13.  Wen-Sen Li (1 out of 1 patent)

14.  Yu-Han Chiu (1 out of 1 patent)

15.  Jui-Hao Lee (1 out of 1 patent)


9 patents:

Company Overview
Everfront Biotech Inc. is a leading biotechnology company specializing in developing innovative drugs and therapies for various medical conditions. With a team of experienced scientists and researchers, Everfront Biotech is committed to advancing healthcare through cutting-edge research and development. The company's mission is to improve the quality of life for patients worldwide by delivering breakthrough treatments and solutions. Visit our website to learn more about our pipeline of products and ongoing research efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#121 in New Taipei

#1,550 in Taiwan

New Taipei, TW
New Taipei, Taiwan
Forward Citations = 0

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Everfront Biotech Inc.. Retrieved from https://idiyas.com/company/everfront-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…